Risks of anticoagulation discontinuation after first venous thromboembolism in inherited thrombophilia: a long-term cohort study. [PDF]
Kim SA +6 more
europepmc +1 more source
Admission antithrombin III activity as a risk-enrichment marker for septic shock below the ISTH overt-DIC threshold. [PDF]
Zhou T +5 more
europepmc +1 more source
Fitusiran treatment modulates the ratio between alpha- and beta-antithrombin isoforms. [PDF]
McCluskey G +10 more
europepmc +1 more source
Non-factor Therapies in Hemophilia: Mechanisms, Clinical Evidence, Patient Management, and Future Perspectives. [PDF]
Nakajima Y, Nogami K.
europepmc +1 more source
A post-marketing surveillance study on the safety and effectiveness of recombinant antithrombin gamma in patients with congenital antithrombin deficiency in Japan. [PDF]
Asakura H +5 more
europepmc +1 more source
Cross-sectional imaging in an inferior vena cava agenesis associated with antiphospholipid syndrome, lower limb, and portomesenteric deep vein thrombosis and renal insufficiency in a young patient: A rare presentation. [PDF]
Linda Sami W +2 more
europepmc +1 more source
The unexpected clot: unilateral brachial artery occlusion unmasking antithrombin III deficiency; case report and therapeutic considerations. [PDF]
Ishqair MA +5 more
europepmc +1 more source
Comparative Analysis of Anticoagulation Stability in Critically Ill Patients Receiving Argatroban for Suspected or Confirmed Heparin-Induced Thrombocytopenia Compared with Unfractionated Heparin: A Retrospective Cohort Study. [PDF]
Khan I +9 more
europepmc +1 more source
Homocystinuria presenting with cerebral venous thrombosis: a case report highlighting progressive thrombosis. [PDF]
Cui X, Chen J, Wang J, Qiu D, Zhang X.
europepmc +1 more source
Proteomic profiling of cephalic vein reveals potential biomarkers for arteriovenous fistula neointimal hyperplasia in ESRD patients. [PDF]
Liang L +5 more
europepmc +1 more source

